Emergent BioSolutions Inc logo

Emergent BioSolutions Inc

7
1
0
NYSE:EBS (USA)   Ordinary Shares
$ 9.60 +0.27 (+2.89%) 12:08 AM EST
At Loss
P/B:
1.32
Market Cap:
$ 507.90M
Enterprise V:
$ 1.29B
Volume:
856.70K
Avg Vol (2M):
1.98M
Trade In:
Volume:
856.70K
At Loss
Avg Vol (2M):
1.98M

Business Description

Emergent BioSolutions Inc logo
Emergent BioSolutions Inc
NAICS : 325412 SIC : 2834
ISIN : US29089Q1058

Share Class Description:

EBS: Ordinary Shares
Description
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
Name Current Vs Industry Vs History
Cash-To-Debt 0.08
Equity-to-Asset 0.26
Debt-to-Equity 2.23
Debt-to-EBITDA -2.3
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.34
Distress
Grey
Safe
Beneish M-Score -4
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -9.7
3-Year Book Growth Rate -23
Name Current Vs Industry Vs History
5-Day RSI 59.43
9-Day RSI 58.07
14-Day RSI 56.89
6-1 Month Momentum % 344.15
12-1 Month Momentum % 311.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.06
Quick Ratio 0.54
Cash Ratio 0.11
Days Inventory 153.55
Days Sales Outstanding 57.87
Days Payable 48.14

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 0.6
Shareholder Yield % 64.35

Financials (Next Earnings Date:2024-11-06)

EBS's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NYSE:EBS

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Emergent BioSolutions Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,074.4
EPS (TTM) ($) -11.24
Beta 2.35
Volatility % 248.97
14-Day RSI 56.89
14-Day ATR ($) 0.723381
20-Day SMA ($) 9.1715
12-1 Month Momentum % 311.33
52-Week Range ($) 1.42 - 15.1
Shares Outstanding (Mil) 52.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Emergent BioSolutions Inc Filings

Filing Date Document Date Form
No Filing Data

Emergent BioSolutions Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Emergent BioSolutions Inc Frequently Asked Questions

What is Emergent BioSolutions Inc(EBS)'s stock price today?
The current price of EBS is $9.60. The 52 week high of EBS is $15.10 and 52 week low is $1.42.
When is next earnings date of Emergent BioSolutions Inc(EBS)?
The next earnings date of Emergent BioSolutions Inc(EBS) is 2024-11-06.
Does Emergent BioSolutions Inc(EBS) pay dividends? If so, how much?
Emergent BioSolutions Inc(EBS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1